LPL Financial’s Psyence Biomedical Warrant PBMWW Stock Holding History

LPL Financial’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Hold	49,095	–	–	﹤0.01%	6198
2026 Q1	$894	Hold	49,095	–	–	﹤0.01%	5962
2025 Q4	$908	Buy	49,095 +19,750	+67%	+$498	﹤0.01%	5866
2025 Q3	$739	Hold	29,345	–	–	﹤0.01%	5788
2025 Q2	$596	Hold	29,345	–	–	﹤0.01%	5544
2025 Q1	$496	Buy	+29,345	New	+$558	﹤0.01%	5341

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

LPL Financial's PBMWW Position: Q2 2026 in Review

LPL Financial held its Psyence Biomedical Warrant (PBMWW) position steady in Q2 2026 at 49,095 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #6198.

LPL Financial first reported a position in PBMWW in Q1 2025 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

LPL Financial held 49,095 shares of Psyence Biomedical Warrant worth $1.19K as of Q2 2026.
LPL Financial left its Psyence Biomedical Warrant share count unchanged in Q2 2026.
Psyence Biomedical Warrant made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6198 holding.
LPL Financial first reported a position in Psyence Biomedical Warrant in Q1 2025 and has held it in 6 quarters since.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.